These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32767859)

  • 1. New blood-borne virus infections among organ transplant recipients: An Australian data-linked cohort study examining donor transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015.
    Waller KMJ; De La Mata NL; Hedley JA; Rosales BM; O'Leary MJ; Cavazzoni E; Ramachandran V; Rawlinson WD; Kelly PJ; Wyburn KR; Webster AC
    Transpl Infect Dis; 2020 Dec; 22(6):e13437. PubMed ID: 32767859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.
    Jones JM; Kracalik I; Levi ME; Bowman JS; Berger JJ; Bixler D; Buchacz K; Moorman A; Brooks JT; Basavaraju SV
    MMWR Recomm Rep; 2020 Jun; 69(4):1-16. PubMed ID: 32584804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
    Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
    Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
    Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Biovigilance in Organ Donation (SAFEBOD): Protocol for a Population-Based Cohort Study.
    Rosales B; Hedley J; De La Mata N; Vajdic CM; Kelly P; Wyburn K; Webster AC;
    JMIR Res Protoc; 2020 Oct; 9(10):e18282. PubMed ID: 33104005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017.
    Bixler D; Annambholta P; Abara WE; Collier MG; Jones J; Mixson-Hayden T; Basavaraju SV; Ramachandran S; Kamili S; Moorman A
    Am J Transplant; 2019 Sep; 19(9):2570-2582. PubMed ID: 30861300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer transmissions and non-transmissions from solid organ transplantation in an Australian cohort of deceased and living organ donors.
    Hedley JA; Vajdic CM; Wyld M; Waller KMJ; Kelly PJ; De La Mata NL; Rosales BM; Wyburn K; Webster AC
    Transpl Int; 2021 Sep; 34(9):1667-1679. PubMed ID: 34448264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual risk of infection with blood-borne viruses in potential organ donors at increased risk of infection: systematic review and meta-analysis.
    Waller KM; De La Mata NL; Kelly PJ; Ramachandran V; Rawlinson WD; Wyburn KR; Webster AC
    Med J Aust; 2019 Nov; 211(9):414-420. PubMed ID: 31489635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening recipients of increased risk donor organs: A multicenter retrospective study.
    Ison MG; Rana MM; Brizendine KD; Chimienti S; Le J; Kfoury R; Mohazabnia P; Theodoropoulos N
    Transpl Infect Dis; 2018 Jun; 20(3):e12862. PubMed ID: 29512233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus).
    Natov SN; Pereira BJ
    Transpl Infect Dis; 2002 Sep; 4(3):117-23. PubMed ID: 12421455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.
    Seem DL; Lee I; Umscheid CA; Kuehnert MJ
    Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study.
    Grossi PA; Dalla Gasperina D; Lombardi D; Ricci A; Piccolo G; Nanni Costa A
    Transpl Int; 2018 Feb; 31(2):212-219. PubMed ID: 29057524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Pruett TL; Clark MA; Taranto SE
    Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.
    Suryaprasad A; Basavaraju SV; Hocevar SN; Theodoropoulos N; Zuckerman RA; Hayden T; Forbi JC; Pegues D; Levine M; Martin SI; Kuehnert MJ; Blumberg EA;
    Am J Transplant; 2015 Jul; 15(7):1827-35. PubMed ID: 25943299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.